Hongyan Su

504 total citations
8 papers, 432 citations indexed

About

Hongyan Su is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Hongyan Su has authored 8 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 2 papers in Pharmacology. Recurrent topics in Hongyan Su's work include Signaling Pathways in Disease (3 papers), Nanoparticle-Based Drug Delivery (2 papers) and Cardiac Fibrosis and Remodeling (2 papers). Hongyan Su is often cited by papers focused on Signaling Pathways in Disease (3 papers), Nanoparticle-Based Drug Delivery (2 papers) and Cardiac Fibrosis and Remodeling (2 papers). Hongyan Su collaborates with scholars based in China and Thailand. Hongyan Su's co-authors include Guangxuan Liu, Cong Luo, Yue Wang, Jingyu Li, Shuo Liu, Qin Chen, Peili Bu, Xiaobin Guo, Shujian Wang and Qin Chen and has published in prestigious journals such as Trends in Pharmacological Sciences, Oncotarget and Molecular and Cellular Biochemistry.

In The Last Decade

Hongyan Su

8 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongyan Su China 8 157 135 117 76 48 8 432
Wenjing Lai China 13 296 1.9× 95 0.7× 69 0.6× 75 1.0× 45 0.9× 36 583
Lixia Zheng China 13 208 1.3× 49 0.4× 26 0.2× 65 0.9× 40 0.8× 30 451
Solmaz Khalighfard Iran 12 312 2.0× 77 0.6× 65 0.6× 81 1.1× 24 0.5× 27 628
Zhida Shen China 11 210 1.3× 208 1.5× 59 0.5× 20 0.3× 38 0.8× 25 546
Hongsuk Park United States 10 276 1.8× 134 1.0× 103 0.9× 23 0.3× 63 1.3× 23 488
Sunil Kumar Surapaneni United States 15 281 1.8× 134 1.0× 96 0.8× 85 1.1× 26 0.5× 22 576
Araceli Lérida‐Viso Spain 7 198 1.3× 110 0.8× 54 0.5× 46 0.6× 19 0.4× 8 462
Jinlong Li China 10 356 2.3× 47 0.3× 48 0.4× 99 1.3× 58 1.2× 12 641
Alejandra Estepa‐Fernández Spain 7 167 1.1× 114 0.8× 57 0.5× 43 0.6× 12 0.3× 8 369
Tsung-Yao Lin Taiwan 7 221 1.4× 70 0.5× 33 0.3× 42 0.6× 98 2.0× 8 452

Countries citing papers authored by Hongyan Su

Since Specialization
Citations

This map shows the geographic impact of Hongyan Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyan Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyan Su more than expected).

Fields of papers citing papers by Hongyan Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongyan Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyan Su. The network helps show where Hongyan Su may publish in the future.

Co-authorship network of co-authors of Hongyan Su

This figure shows the co-authorship network connecting the top 25 collaborators of Hongyan Su. A scholar is included among the top collaborators of Hongyan Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongyan Su. Hongyan Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Guo, Xiaobin, et al.. (2020). SIRT3 Ablation Deteriorates Obesity-Related Cardiac Remodeling by Modulating ROS-NF-κB-MCP-1 Signaling Pathway. Journal of Cardiovascular Pharmacology. 76(3). 296–304. 21 indexed citations
2.
Su, Hongyan & Yi Yang. (2018). The roles of CyPA and CD147 in cardiac remodelling. Experimental and Molecular Pathology. 104(3). 222–226. 11 indexed citations
3.
Pei, Hui, Wei Wang, Di Zhao, et al.. (2018). G Protein-Coupled Estrogen Receptor 1 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy via the Regulation of PI3K-Akt-mTOR Signalling and Autophagy. International Journal of Biological Sciences. 15(1). 81–92. 44 indexed citations
4.
Su, Hongyan, Yan Wang, Shuo Liu, et al.. (2018). Emerging transporter-targeted nanoparticulate drug delivery systems. Acta Pharmaceutica Sinica B. 9(1). 49–58. 61 indexed citations
5.
Chen, Qin, Guangxuan Liu, Shuo Liu, et al.. (2017). Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics. Trends in Pharmacological Sciences. 39(1). 59–74. 203 indexed citations
6.
Su, Hongyan, Tongshuai Chen, Jingyuan Li, et al.. (2017). Correlations of Serum Cyclophilin A and Melatonin Concentrations with Hypertension-induced Left Ventricular Hypertrophy. Archives of Medical Research. 48(6). 526–534. 8 indexed citations
7.
Li, Jingyuan, Tongshuai Chen, Ming Xiao, et al.. (2016). Mouse Sirt3 promotes autophagy in AngII-induced myocardial hypertrophy through the deacetylation of FoxO1. Oncotarget. 7(52). 86648–86659. 59 indexed citations
8.
Su, Hongyan, Jingyuan Li, Tongshuai Chen, et al.. (2016). Melatonin attenuates angiotensin II-induced cardiomyocyte hypertrophy through the CyPA/CD147 signaling pathway. Molecular and Cellular Biochemistry. 422(1-2). 85–95. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026